Aravali Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-12-2024
- Paid Up Capital ₹ 0.50 M
as on 15-12-2024
- Company Age 59 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 50.00 K
as on 15-12-2024
- Revenue 35.24%
(FY 2017)
- Profit 48.82%
(FY 2017)
- Ebitda -18.37%
(FY 2017)
- Net Worth 11.47%
(FY 2017)
- Total Assets 2.38%
(FY 2017)
About Aravali Chemicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹50,000.00.
Narhari Sharma, Manish Sharma, and Deepak Sharma serve as directors at the Company.
- CIN/LLPIN
U99999MH1965PTC013190
- Company No.
013190
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 1965
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Aravali Chemicals Private Limited offer?
Aravali Chemicals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Digestive Medicine, Digestive Herbal Capsule & Tablet, Herbal Piles Medicine, Medical Surgery & Treatment Centres, Medical Treatment Services, Ayurvedic Health Tonic, Blood Purifier, Ayurvedic Joint Pain Relief Medicine.
Who are the key members and board of directors at Aravali Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narhari Sharma  | Director | 27-Apr-1965 | Current |
| Manish Sharma | Director | 30-Mar-2024 | Current |
| Deepak Sharma | Director | 17-Sep-2024 | Current |
Financial Performance of Aravali Chemicals.
Aravali Chemicals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 35.24% increase. The company also saw a substantial improvement in profitability, with a 48.82% increase in profit. The company's net worth Soared by an impressive increase of 11.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aravali Chemicals?
In 2017, Aravali Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Maharashtra Creation Date: 09 Dec 1974 | ₹0.05 M | Open |
How Many Employees Work at Aravali Chemicals?
Aravali Chemicals has a workforce of 1 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aravali Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aravali Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
